Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407419 · ClinicalTrials.gov registry record · NA
The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population
A NA study, sponsored by CorEvitas.
- Completed
- Registry status
- NA
- Development phase
- 538
- Enrollment target
NCT01407419 is a NA study that has completed, run by CorEvitas. The registered enrollment target is 538 participants.
The verdict
NCT01407419, a NA study, has completed, sponsored by CorEvitas.
- COMPLETED
- Registry status
- NA
- Development phase
- 538 participants
- Enrollment target
Study Summary
The Treat to Target Trial is a clinical trial available to new and existing CORRONA (Data Collection Program) sites. Subjects are recruited to participate in this 12 month trial examining outcomes and feasibility of implementing a Treat to Target approach, when compared with a control group of subjects treated with usual care.
Interventions
- OTHER Treatment Acceleration
- OTHER Monthly Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 538 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01407419
The ClinicalTrials.gov registry entry for NCT01407419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 538 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CorEvitas, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment Acceleration is the first listed.
NCT01407419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01407419 about?
NCT01407419 is a clinical study titled "The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population". The Treat to Target Trial is a clinical trial available to new and existing CORRONA (Data Collection Program) sites. Subjects are recruited to participate in this 12 month trial examining outcomes and feasibility of implementing a Treat to Target approach, when compared with a control group of subje...
What is the current status of trial NCT01407419?
This trial is currently completed. It is a NA study. The enrollment target is 538 participants. The study started on 2011-07. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01407419?
The interventions under investigation include: Treatment Acceleration (OTHER), Monthly Assessment (OTHER).
Who is sponsoring clinical trial NCT01407419?
This trial is sponsored by CorEvitas, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.